AHPA participates in USP Botanical Dietary Supplements and Herbal Medicines Expert Committee Meetings

AHPA Alerts

AHPA Alerts

AHPA keeps members and the industry informed of recent news and developments that impact the trade through email alerts. Subscribe to news as it happens or a weekly summary of all alerts.

Subscribe

View recent alerts:

  • Legal Alerts News on dietary supplement laws, regulations and enforcement
  • Science Alerts The latest research on herbs and botanicals
  • Market Alerts Herbal market trends and AHPA-member press releases
  • Media Alerts Media coverage of the herbal industry 
  • Cannabis Alerts The latest research and news about hemp, CBD and medical marijuana
  • Cosmetic Alerts Regulatory updates and personal care product news

Subscribe to AHPA Updates to stay informed about the latest AHPA news and resources.

Recent News

AHPA participates in USP Botanical Dietary Supplements and Herbal Medicines Expert Committee Meetings

Updates from Food Ingredients Expert Committee, Cannabis Expert Panel, Probiotics Expert Panel, Nomenclature subcommittee

Published: Wednesday, March 27, 2019

AHPA Chief Science Officer Holly E. Johnson, Ph.D., represented AHPA member interests at a meeting of the U.S. Pharmacopeial (USP) Convention's Botanical Dietary Supplements and Herbal Medicines Expert Committee held March 26-27.

The expert committee discussed a host of issues, including:

  • New botanical monographs in preparation
  • Botanical identification methods
  • Validation guidelines & method modernization
  • FDA’s Botanical Safety Consortium
  • Updates from Food Ingredients Expert Committee, Cannabis Expert Panel, Probiotics Expert Panel, Nomenclature subcommittee

USP's Botanical Dietary Supplements and Herbal Medicines Expert Committee is responsible for the development of new and revision of existing monographs and their associated reference materials for botanical dietary supplements and herbal medicine ingredients. The expert committee addresses U.S. and global standards.

The expert committee was formed to:

  • Work with FDA and stakeholders to develop new and improve existing botanical dietary supplement and herbal medicine monographs
  • Work with FDA and stakeholders to modernize existing botanical drug monographs
  • Modernize chromatographic methods for identification of articles of botanical origin as appropriate
Print

2022 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.